| |
CEF21  |
|
|
| Cat. No. |
Size |
Price |
Figures |
|---|
RP11782-1 mg
| 1 mg | $ 71.25 | MSDS: 20080715051645 (PDF)
STRUCTURE:
Zoom
References:
- Del Mastro L, et al. Accelerated-intensified cyclophosphamide, epirubicin, and fluorouracil (CEF) compared with standard CEF in metastatic breast cancer patients: results of a multicenter, randomized phase III study of the Italian Gruppo Oncologico Nord-Ouest-Mammella Inter Gruppo Group. J. Clin. Oncol. Apr 2001; 19(8): 2213-2221.
- Del Mastro L, et al. Impact of two different dose-intensity chemotherapy regimens on psychological distress in early breast cancer patients. Eur. J. Cancer. Feb 2002; 38(3): 359-366.
|
|---|
| Full Name | |
| Alias |
Cytomegalovirus, CMV pp65 (417-426) |
Sequence
(one-letter code) |
TPRVTGGGAM | Sequence
(three-letter code) | {THR}{PRO}{ARG}{VAL}{THR}{GLY}{GLY}{GLY}{ALA}{MET} |
|---|
| Description | CEF21 is a CMV pp65 – recombinant protein used for pulsing of antigen-presenting cells, e.g. for research on dendritic cell vaccination, as well as for research on antigen delivery by antigen-presenting cells. CEF21 has HLA-B*0702-restricted epitope from cytomegalovirus (417-426) and is useful in applications such as ELISPOT, intracellular cytokine and CTL assays. |
|---|
| Formula | C38H67N13O13S1 |
|---|
| M.W. | 946.1 |
|---|
| Purity | > 95% |
|---|
| Storage | Store at -20°C. Keep tightly closed. Store in a cool dry place. |
|
